Monogenic diabetes: genes and variants
Explore variant evidence for Monogenic diabetes across 12 analyzed proteins (GCK, HNF4A, ABCC8, KCNJ11, INS and 7 more). Linked ClinVar records include 289 pathogenic or likely pathogenic variants, 167 variants of uncertain significance and 43 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Monogenic diabetes
GCK: Hexokinase-4
It sets the glucose threshold for insulin secretion in pancreatic beta cells and controls hepatic glucose phosphorylation after meals. Heterozygous loss-of-function variants cause GCK-MODY, stronger loss can cause neonatal diabetes, and activating variants can cause hyperinsulinemic hypoglycemia.
235 ClinVar pathogenic / likely pathogenic and 67 uncertain variants in GCK have source records linked to Monogenic diabetes. Association strength is not clinical gene validity.
HNF4A: Hepatocyte nuclear factor 4-alpha
It coordinates transcription of genes involved in hepatic metabolism and pancreatic beta-cell function. Heterozygous pathogenic variants can cause maturity-onset diabetes of the young, often with fetal overgrowth and transient neonatal hyperinsulinemic hypoglycemia in affected families.
50 ClinVar pathogenic / likely pathogenic and 70 uncertain variants in HNF4A have source records linked to Monogenic diabetes. Association strength is not clinical gene validity.
ABCC8: ATP-binding cassette sub-family C member 8
It senses cellular nucleotide levels as the regulatory component of pancreatic beta-cell ATP-sensitive potassium channels and thereby couples glucose metabolism to insulin secretion. Loss-of-function variants cause congenital hyperinsulinism, whereas activating variants can cause neonatal diabetes.
2 ClinVar pathogenic / likely pathogenic and 12 uncertain variants in ABCC8 have source records linked to Monogenic diabetes. Association strength is not clinical gene validity.
KCNJ11: ATP-sensitive inward rectifier potassium channel 11
Together with SUR1, its ATP-sensitive potassium conductance couples pancreatic beta-cell metabolism to membrane depolarization and insulin secretion. Activating variants cause neonatal diabetes, whereas loss-of-function variants can cause congenital hyperinsulinism.
1 ClinVar pathogenic / likely pathogenic and 4 uncertain variants in KCNJ11 have source records linked to Monogenic diabetes. Association strength is not clinical gene validity.
INS: Insulin
After processing to insulin, it lowers blood glucose by promoting cellular glucose uptake, glycogen and lipid synthesis, and suppression of hepatic glucose production. Pathogenic variants can cause neonatal diabetes, maturity-onset diabetes of the young, or hyperproinsulinemia depending on their effect on folding and secretion.
1 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in INS have source records linked to Monogenic diabetes. Association strength is not clinical gene validity.
LEPR: Leptin receptor
It transmits leptin signals to hypothalamic circuits that regulate appetite, body weight, endocrine axes, and energy expenditure. Biallelic loss-of-function variants cause severe early-onset obesity with intense hyperphagia and frequently hypogonadotropic hypogonadism.
0 ClinVar pathogenic / likely pathogenic and 11 uncertain variants in LEPR have source records linked to Monogenic diabetes. Association strength is not clinical gene validity.
INSR: Insulin receptor
Its activation by insulin coordinates glucose uptake, metabolism, growth, and gene expression through PI3K-AKT and MAPK pathways. Biallelic severe loss-of-function variants cause Donohue or Rabson-Mendenhall syndromes, while heterozygous variants can cause severe insulin resistance.
0 ClinVar pathogenic / likely pathogenic and 8 uncertain variants in INSR have source records linked to Monogenic diabetes. Association strength is not clinical gene validity.
PDX1: Pancreas/duodenum homeobox protein 1
It directs pancreatic development and later maintains beta-cell identity and insulin transcription. Biallelic severe loss can cause pancreatic agenesis and neonatal diabetes, while heterozygous variants can cause maturity-onset diabetes of the young.
0 ClinVar pathogenic / likely pathogenic and 9 uncertain variants in PDX1 have source records linked to Monogenic diabetes. Association strength is not clinical gene validity.
ALMS1: Centrosome-associated protein ALMS1
It contributes to primary-cilium function, intracellular trafficking, and metabolic homeostasis in multiple tissues. Biallelic pathogenic variants cause Alstrom syndrome, which typically combines retinal degeneration, hearing loss, obesity, insulin resistance, and cardiomyopathy.
0 ClinVar pathogenic / likely pathogenic and 7 uncertain variants in ALMS1 have source records linked to Monogenic diabetes. Association strength is not clinical gene validity.
GATA6: Transcription factor GATA-6
It regulates developmental programs in the pancreas, heart, gut, and other endoderm-derived tissues. Haploinsufficiency is a major cause of pancreatic agenesis and neonatal diabetes and can also produce congenital heart disease and other developmental abnormalities.
0 ClinVar pathogenic / likely pathogenic and 5 uncertain variants in GATA6 have source records linked to Monogenic diabetes. Association strength is not clinical gene validity.
HNF1B: Hepatocyte nuclear factor 1-beta
It controls developmental and metabolic gene programs in kidney, pancreas, liver, and genital tract. Haploinsufficiency or intragenic pathogenic variants cause a multisystem disorder often featuring renal cysts or malformations, maturity-onset diabetes of the young, hypomagnesemia, and genital abnormalities.
0 ClinVar pathogenic / likely pathogenic and 7 uncertain variants in HNF1B have source records linked to Monogenic diabetes. Association strength is not clinical gene validity.
SLC2A2: Solute carrier family 2, facilitated glucose transporter member 2
It enables high-capacity bidirectional glucose transport in liver, intestine, kidney, and pancreatic cells, matching transport to changing glucose concentrations. Biallelic loss-of-function variants cause Fanconi-Bickel syndrome with hepatomegaly, abnormal glucose homeostasis, and renal tubular dysfunction.
0 ClinVar pathogenic / likely pathogenic and 3 uncertain variants in SLC2A2 have source records linked to Monogenic diabetes. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): MC4R, LMNA, FOXP3, LEP and PPARG.
ClinVar pathogenic and likely pathogenic variants linked to Monogenic diabetes
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| GCK Q38P | 38 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK R43C | 43 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK R43H | 43 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK M57K | 57 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK V62M | 62 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK V62A | 62 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK G117R | 117 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK L122I | 122 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK I130T | 130 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK F150S | 150 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK F150L | 150 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK G175R | 175 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK G178R | 178 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK A188T | 188 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK I189T | 189 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK I189M | 189 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK M202T | 202 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK A208T | 208 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK M210T | 210 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK T228R | 228 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK T228M | 228 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK M235T | 235 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK G246R | 246 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK R250C | 250 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK G258D | 258 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK G258S | 258 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK A259T | 259 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK G261R | 261 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK R275G | 275 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK G294D | 294 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK G295D | 295 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK E300K | 300 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK E339K | 339 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK C371R | 371 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK V374M | 374 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK V374E | 374 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK R377S | 377 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK R377H | 377 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK A378P | 378 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK A378T | 378 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK A378G | 378 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK A379E | 379 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK A379V | 379 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK M381T | 381 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK C382G | 382 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK S383L | 383 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK A384E | 384 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK A384V | 384 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK G385R | 385 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK L386P | 386 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK A387E | 387 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK A387V | 387 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK R392C | 392 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK R392S | 392 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK R394S | 394 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK R397L | 397 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK R397C | 397 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK G410C | 410 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK G410R | 410 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
| GCK G410D | 410 | Hexokinase | Pathogenic / likely pathogenic (★★★) |
Showing 60 of 289.
Uncertain variants prioritized for review in Monogenic diabetes
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| HNF4A G124D | 124 | Nuclear receptor | Uncertain (★★★) | +7: 2 other pathogenic changes within 3 positions; G124S at the same position is pathogenic; seen in 1.4e-06 of gnomAD DNA copies; REVEL 0.969 |
| ABCC8 R1379S | 1379 | ABC transporter 2 | Uncertain (★★) | +7: 2 other pathogenic changes within 3 positions; R1379H at the same position is pathogenic; seen in 6.6e-06 of gnomAD DNA copies; REVEL 0.975 |
| GCK S441L | 441 | Hexokinase | Uncertain (★★★) | +7: in a 3D region that tolerates change poorly (3R); S441W at the same position is pathogenic; seen in 2.1e-06 of gnomAD DNA copies; REVEL 0.984 |
| GCK G318W | 318 | Hexokinase | Uncertain (★★★) | +7: 2 other pathogenic changes within 3 positions; G318R at the same position is pathogenic; seen in 1.4e-06 of gnomAD DNA copies; REVEL 0.900 |
| HNF4A D282N | 282 | NR LBD | Uncertain (★★★) | +7: 2 other pathogenic changes within 3 positions; D282Y at the same position is pathogenic; seen in 6.8e-06 of gnomAD DNA copies; REVEL 0.791 |
| HNF4A V130F | 130 | Nuclear receptor | Uncertain (★★★) | +6: 2 other pathogenic changes within 3 positions; V130I at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| HNF4A W201S | 201 | NR LBD | Uncertain (★★★) | +6: 2 other pathogenic changes within 3 positions; W201C at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99 |
| GCK M224R | 224 | Hexokinase | Uncertain (★★★) | +6: 6 other pathogenic changes within 3 positions; M224T at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99 |
| HNF4A G335R | 335 | NR LBD | Uncertain (★★★) | +6: 4 other pathogenic changes within 3 positions; G335V at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99 |
| GCK M37K | 37 | Hexokinase | Uncertain (★★★) | +6: 7 other pathogenic changes within 3 positions; M37R at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.96 |
| GCK G117D | 117 | Hexokinase | Uncertain (★★★) | +6: 2 other pathogenic changes within 3 positions; G117V at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.93 |
| GCK C220F | 220 | Hexokinase | Uncertain (★★★) | +6: 3 other pathogenic changes within 3 positions; C220Y at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99 |
| HNF4A E285D | 285 | NR LBD | Uncertain (★★★) | +6: 2 other pathogenic changes within 3 positions; E285Q at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99 |
| GCK D124V | 124 | Hexokinase | Uncertain (★★★) | +6: 5 other pathogenic changes within 3 positions; D124H at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.97 |
| GCK G385E | 385 | Hexokinase | Uncertain (★★★) | +6: 19 other pathogenic changes within 3 positions; G385R at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99 |
| GCK G175V | 175 | Hexokinase | Uncertain (★★★) | +6: 6 other pathogenic changes within 3 positions; G175R at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.88 |
| GCK V277E | 277 | Hexokinase | Uncertain (★★★) | +6: 6 other pathogenic changes within 3 positions; V277G at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.97 |
| GCK G117S | 117 | Hexokinase | Uncertain (★★★) | +6: 2 other pathogenic changes within 3 positions; G117V at the same position is pathogenic; REVEL 0.933 |
| GCK F419L | 419 | Hexokinase | Uncertain (★★★) | +6: 3 other pathogenic changes within 3 positions; F419S at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| GCK F419V | 419 | Hexokinase | Uncertain (★★★) | +6: 3 other pathogenic changes within 3 positions; F419S at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.95 |
| GCK V33E | 33 | Hexokinase | Uncertain (★★★) | +6: 3 other pathogenic changes within 3 positions; V33A at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.94 |
| GCK H156D | 156 | Hexokinase | Uncertain (★★★) | +6: 8 other pathogenic changes within 3 positions; H156Y at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.95 |
| GCK G294R | 294 | Hexokinase | Uncertain (★★★) | +6: 5 other pathogenic changes within 3 positions; G294V at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99 |
| HNF4A R136Q | 136 | Uncertain (★★★) | +6: 3 other pathogenic changes within 3 positions; R136W at the same position is pathogenic; REVEL 0.869 | |
| GCK G295R | 295 | Hexokinase | Uncertain (★★★) | +6: 5 other pathogenic changes within 3 positions; G295V at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99 |
| GCK A384P | 384 | Hexokinase | Uncertain (★★★) | +6: 21 other pathogenic changes within 3 positions; A384E at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99 |
| GCK E339D | 339 | Hexokinase | Uncertain (★★★) | +6: 4 other pathogenic changes within 3 positions; E339K at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.92 |
| GCK V33G | 33 | Hexokinase | Uncertain (★★★) | +6: 3 other pathogenic changes within 3 positions; V33A at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.73 |
| GCK F423S | 423 | Hexokinase | Uncertain (★★★) | +6: 2 other pathogenic changes within 3 positions; F423Y at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.98 |
| GCK R250P | 250 | Hexokinase | Uncertain (★★★) | +6: 2 other pathogenic changes within 3 positions; R250C at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.91 |
| HNF4A R331S | 331 | NR LBD | Uncertain (★★★) | +6: 6 other pathogenic changes within 3 positions; R331L at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.737 |
| GCK V226L | 226 | Hexokinase | Uncertain (★★★) | +6: 9 other pathogenic changes within 3 positions; V226A at the same position is pathogenic; seen in 6.6e-06 of gnomAD DNA copies; REVEL 0.668 |
| GCK R36Q | 36 | Hexokinase | Uncertain (★★★) | +6: 7 other pathogenic changes within 3 positions; R36W at the same position is pathogenic; REVEL 0.833 |
| GCK I189V | 189 | Hexokinase | Uncertain (★★★) | +6: 9 other pathogenic changes within 3 positions; I189T at the same position is pathogenic; seen in 3.4e-06 of gnomAD DNA copies; REVEL 0.650 |
Which prediction tools work for Monogenic diabetes
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- CATVariant: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 96 out of 100
- MetaLR: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 95 out of 100
- CADD: 94 out of 100
- MutPred: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 88 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 87 out of 100
- SIFT: 84 out of 100
- EVE: 64 out of 100
- SpliceAI: 54 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 50 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Maturity-onset diabetes of the young also has ClinVar records linked to GCK variants; they fall in the same places as the Monogenic diabetes variants (68 pathogenic / likely pathogenic).
- Familial hyperinsulinemic hypoglycemia also has ClinVar records linked to GCK variants; they fall in the same places as the Monogenic diabetes variants (7 pathogenic / likely pathogenic).
- Permanent neonatal diabetes mellitus also has ClinVar records linked to GCK variants; they fall in the same places as the Monogenic diabetes variants (4 pathogenic / likely pathogenic).
- Maturity-onset diabetes of the young also has ClinVar records linked to HNF4A variants; they fall partly in the same places as the Monogenic diabetes variants (9 pathogenic / likely pathogenic).
- Familial hyperinsulinism also has ClinVar records linked to ABCC8 variants; they fall mostly in different places as the Monogenic diabetes variants (36 pathogenic / likely pathogenic).
- Familial hyperinsulinemic hypoglycemia also has ClinVar records linked to ABCC8 variants; they fall mostly in different places as the Monogenic diabetes variants (31 pathogenic / likely pathogenic).
- Type 2 diabetes mellitus also has ClinVar records linked to ABCC8 variants; they fall mostly in different places as the Monogenic diabetes variants (27 pathogenic / likely pathogenic).
- Diabetes mellitus, transient also has ClinVar records linked to ABCC8 variants; they fall mostly in different places as the Monogenic diabetes variants (19 pathogenic / likely pathogenic).
- Diabetes mellitus, permanent also has ClinVar records linked to ABCC8 variants; they fall mostly in different places as the Monogenic diabetes variants (17 pathogenic / likely pathogenic).
- Diabetes mellitus also has ClinVar records linked to KCNJ11 variants; they fall mostly in different places as the Monogenic diabetes variants (12 pathogenic / likely pathogenic).
- Familial hyperinsulinemic hypoglycemia also has ClinVar records linked to KCNJ11 variants; they fall mostly in different places as the Monogenic diabetes variants (7 pathogenic / likely pathogenic).
- Diabetes mellitus, permanent also has ClinVar records linked to KCNJ11 variants; they fall mostly in different places as the Monogenic diabetes variants (7 pathogenic / likely pathogenic).
- Familial hyperinsulinism also has ClinVar records linked to KCNJ11 variants; they fall mostly in different places as the Monogenic diabetes variants (6 pathogenic / likely pathogenic).
- Permanent neonatal diabetes mellitus also has ClinVar records linked to KCNJ11 variants; they fall mostly in different places as the Monogenic diabetes variants (6 pathogenic / likely pathogenic).
- Diabetes mellitus also has ClinVar records linked to INS variants; they fall mostly in different places as the Monogenic diabetes variants (12 pathogenic / likely pathogenic).
- Diabetes mellitus, permanent also has ClinVar records linked to INS variants; they fall mostly in different places as the Monogenic diabetes variants (11 pathogenic / likely pathogenic).
- Type 1 diabetes mellitus also has ClinVar records linked to INS variants; they fall mostly in different places as the Monogenic diabetes variants (8 pathogenic / likely pathogenic).
- Hyperproinsulinemia also has ClinVar records linked to INS variants; they fall mostly in different places as the Monogenic diabetes variants (6 pathogenic / likely pathogenic).
- Maturity-onset diabetes of the young also has ClinVar records linked to INS variants; they fall mostly in different places as the Monogenic diabetes variants (3 pathogenic / likely pathogenic).
Diseases related to Monogenic diabetes
- Type 2 diabetes mellitus, also linked to ABCC8, GCK, HNF1B, HNF4A and 6 more
- Maturity-onset diabetes of the young, also linked to ABCC8, GCK, HNF1B, HNF4A and 3 more
- Diabetes mellitus, also linked to ABCC8, HNF1B, HNF4A, INS and 3 more
- Permanent neonatal diabetes mellitus, also linked to ABCC8, GCK, INS and KCNJ11
- Familial hyperinsulinemic hypoglycemia, also linked to ABCC8, GCK and KCNJ11
- Familial hyperinsulinism, also linked to ABCC8, GCK and KCNJ11
- Diabetes mellitus, permanent, also linked to ABCC8, INS and KCNJ11
- Renal cysts and diabetes syndrome, also linked to HNF1B and HNF4A
- Atrial septal defect, also linked to ABCC8 and GATA6
- Diabetes mellitus, transient, also linked to ABCC8 and KCNJ11
- Type 1 diabetes mellitus, also linked to INS and INSR
- Retinitis pigmentosa, also linked to ALMS1
Frequently asked questions
Which genes have records linked to Monogenic diabetes?
This view contains 12 analyzed proteins: GCK, HNF4A, ABCC8, KCNJ11, INS and 7 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 289 pathogenic or likely pathogenic variants, 167 variants of uncertain significance and 43 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 34 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 547 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center